English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Arena Pharmaceuticals
Cheyenne Dickerson
| May 21, 2017
Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results
Carol Ostrow
| Feb 16, 2017
Arena presenting latest data on ulcerative colitis drug at summit
Carol Ostrow
| Jan 13, 2017
Eisai acquires rights to Lorcaserin HCI for weight control
Jeff Gantt
| Dec 24, 2016
ANVISA approves Belviq in Brazil
Carol Ostrow
| Dec 16, 2016
Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation
Jeff Gantt
| Dec 14, 2016
Arena finalizes enrollment in ralinepag trial
Amanda Rupp
| May 26, 2016
Arena Pharmaceuticals welcomes new president, CEO
Trending
+
Pharmaceuticals
Patient Daily
| Jun 18, 2025
ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+
Pharmaceuticals
Patient Daily
| Jun 16, 2025
American Consumer Institute questions hospital use of 340B Drug Pricing Program
+
Pharmaceuticals
Patient Daily
| Jun 13, 2025
Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
